deltatrials
Completed NA INTERVENTIONAL 2-arm NCT00766207

Electronic Notification of Teratogenic Risks (PREVENT)

Preconception Risk Evaluation Via Electronic Medical Record Notification of Teratogenic Risks

Sponsor: Agency for Healthcare Research and Quality (AHRQ)

Conditions Abnormalities, Drug-Induced Contraception Teratogens
Interventions Clinical decision support stream-lined clinical alert
Updated 5 times since 2017 Last updated: May 11, 2011 Started: Oct 31, 2008 Primary completion: Apr 30, 2010 Completion: May 31, 2011
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Abnormalities, Drug-Induced and Contraception, this trial is completed. The trial is conducted by Agency for Healthcare Research and Quality (AHRQ) and has accumulated 5 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Agency for Healthcare Research and Quality (AHRQ)
  • University of Pittsburgh
Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations